Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-7 av 7

2019
1 Cuminetti, Vincent; Arranz, Lorena.
Bone Marrow Adipocytes: The Enigmatic Components of the Hematopoietic Stem Cell Niche. Journal of Clinical Medicine 2019 ;Volum 8.(5) s. 707-
UiT Untitled
 
2018
2 Bernal Mera, Aurora; Arranz, Lorena.
Nestin-expressing progenitor cells: function, identity and therapeutic implications. Cellular and Molecular Life Sciences (CMLS) 2018 ;Volum 75.(12) s. 2177-2195
UiO UiT UNN Untitled
 
3 Grimolizzi, Franco; Arranz, Lorena.
Multiple faces of succinate beyond metabolism in blood. Haematologica 2018 ;Volum 103.(10) s. 1586-1592
UiO UiT UNN Untitled
 
4 Ho, Ya-Hsuan; del Toro, Raquel; Rivera-Torres, Jose; Rak, Justyna; Korn, Claudia; García-García, Andrés; Kubovcakova, Lucia; Macías, David; Arranz, Lorena; González-Gómez, Cristina; Wittner, Monika; Nienhold, Ronny; Waller, Amie K; Foster, Holly R; López-Otin, Carlos; Johnson, Randall S; Nerlov, Claus; Vainchenker, William; Ghevaert, Cedric; Louache, Fawzia; Skoda, Radek C.; Andrés, Vicente; Mendez-Ferrer, Simon.
Aging of Bone Marrow Microenvironment Promotes Myeloid Bias of Hematopoietic Progenitors and Is a Target in Age-Related Myeloproliferative Neoplasms. Blood 2018 ;Volum 132. Suppl. 1 s. 3842-3842
UiT Untitled
 
5 Konieczny, Joanna; Arranz, Lorena.
Updates on old and weary haematopoiesis. International Journal of Molecular Sciences 2018 ;Volum 19:2567.(9) s. 1-14
UiO UiT UNN Untitled
 
6 Thiyagarajan, Dhivya; Pedersen, Hege Lynum; Seredkina, Natalya; Horvei, Kjersti Daae; Arranz, Lorena; Sonneveld, Ramon; Nijenhuis, Tom; van der Vlag, Johan; Rekvig, Ole Petter.
IL-1β Promotes a New Function of DNase I as a Transcription Factor for the Fas Receptor Gene. Frontiers in Cell and Developmental Biology 2018 ;Volum 6.
UiT UNN Untitled
 
2017
7 Arranz, Lorena; Arriero Sanchez, Maria Del Mar; Villatoro, Alicia.
Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications. Blood reviews 2017 ;Volum 31.(5) s. 306-317
UiO UiT UNN Untitled